Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent infection in patients with inflammatory bowel disease
Background: Patients with inflammatory bowel disease (IBD) are at an increased risk of developing Clostridioides difficile infection (CDI). Treatment of CDI in patients with IBD is challenging due to higher failure rates and concomitant IBD activity. Objectives: We performed a multicentre cohort stu...
Main Authors: | Emilie (E.) van Lingen, Simon (S. M. D.) Baunwall, Simone (S. C.) Lieberknecht, Nicolas (N.) Benech, Gianluca (G.) Ianiro, Harry (H.) Sokol, Alessandro (A.) Gasbarrini, Giovanni (G.) Cammarota, Marcel (M. K.) Eriksen, Andrea (A. E.) van der Meulen-de Jong, Elizabeth (E. M.) Terveer, Hein (H. W.) Verspaget, Maria (M.) Vehreschild, Christian (C. L.) Hvas, Josbert (J. J.) Keller |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-03-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848231156285 |
Similar Items
-
Fecal microbiota transplantation is associated with improved aspects of mental health of patients with recurrent Clostridioides difficile infections
by: Eline Koppenol, et al.
Published: (2022-07-01) -
Update on fecal microbiota transplantation
by: M. Fiorani, et al.
Published: (2023-10-01) -
European academic faecal microbiota transplantation (EURFMT) network: improving the safety and quality of microbiome therapies in Europe
by: C. Lodberg Hvas, et al.
Published: (2023-11-01) -
Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent <i>Clostridioides difficile</i> Infection from a Randomized Controlled Trial and Review of the Literature
by: R. E. Ooijevaar, et al.
Published: (2021-03-01) -
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
by: Stefano Bibbò, et al.
Published: (2020-06-01)